Search results for RPTOR

202 hits were found for RPTOR

# Family MCID Name MIFTS Score
1
P TBR001 Tuberous Sclerosis 69 11.949
2
c TBR025 Tuberous Sclerosis 1 84 8.541
3
c TBR026 Tuberous Sclerosis 2 71 8.228
4
P BRD002 Bardet-Biedl Syndrome 66 8.228
5
SBP002 Subependymal Glioma 41 8.228
6
P BNG030 Benign Ependymoma 51 8.228
7
DSS008 Disease of Mental Health 74 8.228
8
P CWD010 Cowden Syndrome 70 8.228
9
KDN015 Kidney Angiomyolipoma 46 8.228
10
GLM045 Glioma 62 2.086
11
GST103 Gastric Cancer, Hereditary Diffuse 68 1.840
12
BLD173 Bladder Small Cell Carcinoma 44 1.816
13
P GST053 Gastric Cancer 82 1.806
14
SML009 Small Intestine Adenocarcinoma 57 1.675
15
c PLY162 Polyposis Syndrome, Hereditary Mixed, 1 59 1.551
16
c CLR087 Colorectal Cancer 12 34 1.551
17
END057 Endometrial Cancer 76 1.537
18
P PRS040 Prostate Cancer 95 1.522
19
c BNM022 Bone Mineral Density Quantitative Trait Locus 8 45 1.521
20
P OST002 Osteoporosis 76 1.521
21
P BNM029 Bone Mineral Density Quantitative Trait Locus 15 48 1.521
22
P BRS047 Breast Cancer 97 1.521
23
GST040 Gastric Adenocarcinoma 66 1.431
24
P LNG032 Lung Cancer 98 1.423
25
CLN015 Colon Adenocarcinoma 64 1.416
26
LNG039 Lung Squamous Cell Carcinoma 57 1.400
27
ADN011 Adenoid Cystic Carcinoma 68 1.351
28
ADN089 Adenosquamous Lung Carcinoma 51 1.301
29
P TMR010 Tumor Predisposition Syndrome 69 1.266
30
P LNG064 Lung Cancer Susceptibility 3 69 1.266
31
BRN015 Bronchiolo-Alveolar Adenocarcinoma 55 1.266
32
STT001 Status Epilepticus 58 1.252
33
PLM173 Palmoplantar Hyperkeratosis with Squamous Cell Carcinoma of Skin and 46,xx Sex Reversal 34 1.194
34
SKN022 Skin Squamous Cell Carcinoma 53 1.194
35
PSD011 Pseudovascular Skin Squamous Cell Carcinoma 16 1.194
36
P RSP003 Respiratory Failure 73 1.166
37
HGH043 High Grade Glioma 46 1.166
38
GLL048 Glial Tumor 51 1.166
39
P BLD134 Bladder Cancer 79 1.156
40
P INF032 Infertility 60 1.096
41
P GLM040 Glioma Susceptibility 1 70 1.077
42
PST011 Pustulosis of Palm and Sole 52 1.054
43
P PSR002 Psoriasis 63 1.054
44
P PST059 Pustular Psoriasis 37 1.054
45
P OVR042 Ovarian Cancer 88 1.008
46
CYS001 Cystic Fibrosis 77 1.004
47
c FBR046 Fibrosis of Extraocular Muscles, Congenital, 1 58 1.004
48
ATS010 Autosomal Recessive Disease 42 1.004
49
P FTT008 Fatty Liver Disease, Nonalcoholic 1 48 1.004
50
NNL005 Non-Alcoholic Fatty Liver Disease 63 1.004
51
P ADL010 Adult Respiratory Distress Syndrome 70 1.004
52
c MSM022 Mismatch Repair Cancer Syndrome 1 69 0.920
53
c GLM043 Glioma Susceptibility 9 30 0.920
54
c GLM025 Glioma Susceptibility 2 30 0.920
55
c GLM047 Glioma Susceptibility 3 32 0.920
56
MNN043 Meningioma, Familial 79 0.920
57
P OLG002 Oligodendroglioma 66 0.920
58
BRS099 Breast Ductal Carcinoma 61 0.920
59
ESP021 Esophageal Cancer 84 0.870
60
END041 Endometrial Adenocarcinoma 63 0.870
61
SQM006 Squamous Cell Carcinoma 59 0.754
62
PPL004 Papillary Squamous Carcinoma 39 0.731
63
c PRS097 Prostate Cancer, Hereditary, 1 38 0.700
64
c PRS114 Prostate Cancer, Hereditary, 2 33 0.700
65
c PRS070 Prostate Cancer, Hereditary, 12 22 0.700
66
c PRS071 Prostate Cancer, Hereditary, 13 25 0.700
67
c PRS117 Prostate Cancer, Hereditary, 11 24 0.700
68
P LNG021 Lung Occult Small Cell Carcinoma 20 0.700
69
LNG019 Lung Combined Type Small Cell Carcinoma 34 0.700
70
LNG111 Lung Non-Squamous Non-Small Cell Carcinoma 56 0.700
71
PRS015 Prostate Signet Ring Cell Adenocarcinoma 25 0.700
72
P BLD062 Bile Duct Cancer 69 0.667
73
MLN065 Melanocytic Nevus Syndrome, Congenital 62 0.597
74
LNG012 Lung Occult Squamous Cell Carcinoma 20 0.597
75
LNG007 Lung Mixed Small Cell and Squamous Cell Carcinoma 20 0.597
76
P PNC035 Pancreatic Cancer 87 0.587
77
P LMN015 Luminal Breast Carcinoma a 35 0.517
78
LMN016 Luminal Breast Carcinoma B 29 0.517
79
DST001 Distal Biliary Tract Carcinoma 24 0.517
80
SKN019 Skin Melanoma 70 0.517
81
c BSL024 Basal Cell Carcinoma 1 55 0.472
82
RMB001 Rombo Syndrome 29 0.472
83
P TRC095 Trichoepithelioma, Multiple Familial, 1 34 0.472
84
P RTH006 Rothmund-Thomson Syndrome, Type 2 67 0.472
85
c BSL034 Basal Cell Carcinoma 7 25 0.472
86
BSL044 Basal Cell Carcinoma, Infundibulocystic 37 0.472
87
c BSL007 Basal Cell Carcinoma 67 0.472
88
NDL009 Nodular Basal Cell Carcinoma 40 0.472
89
MTT001 Metatypical Basal Cell Carcinoma 32 0.472
90
PGM002 Pigmented Basal Cell Carcinoma 31 0.472
91
ANL013 Anal Margin Basal Cell Carcinoma 18 0.472
92
SBC013 Sebaceous Basal Cell Carcinoma 13 0.472
93
MCR016 Micronodular Basal Cell Carcinoma 35 0.472
94
ADM002 Adamantinoid Basal Cell Epithelioma 20 0.472
95
CLR015 Clear Cell Basal Cell Carcinoma 41 0.472
96
ADN015 Adenoid Basal Cell Carcinoma 32 0.472
97
INF027 Infiltrative Basal Cell Carcinoma 34 0.472
98
CYS004 Cystic Basal Cell Carcinoma 37 0.472
99
SRC003 Sarcomatoid Basal Cell Carcinoma 29 0.472
100
SGN001 Signet Ring Basal Cell Carcinoma 34 0.472
101
ORL011 Oral Cancer 60 0.472
102
INF057 Inflammatory Linear Verrucous Epidermal Nevus 34 0.472
103
9Q2001 9q22.3 Microdeletion 24 0.472
104
LNR004 Linear Porokeratosis 34 0.472
105
SQM013 Squamous Cell Carcinoma, Head and Neck 75 0.422
106
THY121 Thyroid Gland Anaplastic Carcinoma 66 0.422
107
LNG115 Lung Sarcomatoid Carcinoma 37 0.422
108
c HYP595 Hypertension, Essential 84 0.384
109
P SLV026 Salivary Gland Carcinoma 59 0.366
110
END032 Endometrial Clear Cell Adenocarcinoma 33 0.366
111
CRV013 Cervical Adenoid Cystic Carcinoma 35 0.366
112
MCP006 Mucoepidermoid Carcinoma 48 0.366
113
P MLN008 Melanoma 75 0.366
114
OVR062 Ovary Serous Adenocarcinoma 25 0.366
115
EPD081 Epidermoid Brain Cyst 24 0.366
116
PRM126 Primary Peritoneal Carcinoma 61 0.366
117
OVR063 Overnutrition 42 0.313
118
BRN056 Bronchopulmonary Dysplasia 57 0.313
119
LNG099 Lung Disease 62 0.313
120
OST159 Osteogenic Sarcoma 66 0.298
121
LNG117 Lung Pleomorphic Carcinoma 19 0.298
122
LNG091 Lung Mucoepidermoid Carcinoma 32 0.298
123
LNG017 Lung Giant Cell Carcinoma 52 0.298
124
LNG020 Lung Oat Cell Carcinoma 51 0.298
125
P LNG035 Lung Large Cell Carcinoma 53 0.298
126
LNG011 Lung Adenoid Cystic Carcinoma 35 0.298
127
CRC021 Carcinosarcoma 62 0.298
128
MRK001 Merkel Cell Carcinoma 64 0.298
129
ESP027 Esophagus Squamous Cell Carcinoma 45 0.298
130
PNS010 Penis Squamous Cell Carcinoma 46 0.298
131
OVR044 Ovarian Carcinosarcoma 47 0.298
133
HLR002 Hilar Lung Carcinoma 25 0.298
134
LNG014 Lung Superior Sulcus Carcinoma 15 0.298
135
BSL003 Basaloid Lung Carcinoma 37 0.298
136
LNG006 Lung Occult Large Cell Carcinoma 14 0.298
137
c LNG001 Lung Clear Cell Carcinoma 31 0.298
138
LNG002 Lung Combined Large Cell Neuroendocrine Carcinoma 19 0.298
139
PNS005 Penis Mixed Squamous Cell Carcinoma 12 0.298
140
LNG003 Lung Carcinoma in Situ 38 0.298
141
CLT003 Colitis 63 0.221
142
ALP042 Alpha/beta T-Cell Lymphopenia with Gamma/delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity 65 0.221
143
c FML346 Familial Adenomatous Polyposis 1 65 0.221
144
c THY107 Thymoma, Familial 42 0.221
145
P MYC084 Mycobacterium Tuberculosis 1 68 0.221
146
P THY023 Thymoma 64 0.221
147
GLB002 Glioblastoma 67 0.221
148
LPD008 Lipid Metabolism Disorder 61 0.221
149
PLM001 Pulmonary Tuberculosis 69 0.221
150
PNC041 Pancreatic Ductal Adenocarcinoma 51 0.221
151
P NRF002 Neurofibromatosis 60 0.221
152
ULC004 Ulcerative Colitis 74 0.221
153
FTT001 Fatty Liver Disease 61 0.221
154
HYP266 Hypoxia 56 0.221
155
c MJR022 Major Affective Disorder 8 37 0.157
156
c BDY007 Body Mass Index Quantitative Trait Locus 1 40 0.157
157
c TYP009 Type 2 Diabetes Mellitus 91 0.157
158
c SML038 Small Cell Cancer of the Lung 68 0.157
159
c NPH055 Nephrotic Syndrome, Type 1 52 0.157
160
c FNC027 Fanconi Anemia, Complementation Group a 80 0.157
161
P BDY004 Body Mass Index Quantitative Trait Locus 11 82 0.157
162
c BDY005 Body Mass Index Quantitative Trait Locus 9 47 0.157
163
c BDY006 Body Mass Index Quantitative Trait Locus 8 43 0.157
164
c BDY010 Body Mass Index Quantitative Trait Locus 4 46 0.157
165
c MJR024 Major Affective Disorder 9 40 0.157
166
c BDY020 Body Mass Index Quantitative Trait Locus 19 51 0.157
167
c BDY011 Body Mass Index Quantitative Trait Locus 10 45 0.157
168
AGN018 Agenesis of Corpus Callosum, Cardiac, Ocular, and Genital Syndrome 58 0.157
169
P AST005 Asthma 75 0.157
170
c BDY012 Body Mass Index Quantitative Trait Locus 7 43 0.157
171
LPT014 Leptin Deficiency or Dysfunction 77 0.157
172
c BDY019 Body Mass Index Quantitative Trait Locus 18 46 0.157
173
c BDY015 Body Mass Index Quantitative Trait Locus 12 46 0.157
174
IGR001 Ige Responsiveness, Atopic 58 0.157
175
c MST023 Mesothelioma, Malignant 56 0.157
176
c BDY017 Body Mass Index Quantitative Trait Locus 14 45 0.157
177
c NPH049 Nephrotic Syndrome, Type 2 49 0.157
178
c FNC042 Fanconi Anemia, Complementation Group D2 54 0.157
179
PRS129 Prostatic Hyperplasia, Benign 48 0.157
180
HPT079 Hepatoid Adenocarcinoma 39 0.157
181
NNL006 Non-Alcoholic Steatohepatitis 54 0.157
182
P FLL037 Follicular Lymphoma 66 0.157
183
MLG169 Malignant Astrocytoma 57 0.157
184
FDL002 Food Allergy 47 0.157
185
P BNG032 Benign Mesothelioma 53 0.157
186
P MLN007 Male Infertility 56 0.157
187
SBP001 Subependymal Giant Cell Astrocytoma 45 0.157
188
P BPL003 Bipolar Disorder 56 0.157
189
P ADN016 Adenocarcinoma 63 0.157
190
P MYP004 Myopathy 67 0.157
191
PRS021 Prostatic Adenoma 43 0.157
192
P PLM036 Pulmonary Fibrosis 65 0.157
193
c ACT027 Acute Pancreatitis 60 0.157
194
HYP066 Hyperglycemia 60 0.157
195
MCR013 Microphthalmia 59 0.157
196
PRS045 Prostatic Hypertrophy 53 0.157
197
MLG077 Malignant Peripheral Nerve Sheath Tumor 53 0.157
198
CRB039 Cerebrovascular Disease 65 0.157
199
ALL006 Allergic Asthma 55 0.157
200
P MSC003 Muscular Atrophy 52 0.157
201
END086 End Stage Renal Disease 54 0.157
202
P RRT020 Rare Tumor 39 0.157
Content
Loading form....